Citigroup’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.3K | Buy |
31,205
+25,056
| +407% | +$35.6K | ﹤0.01% | 4096 |
|
|
2025
Q1 | $9.41K | Sell |
6,149
-53,823
| -90% | -$82.3K | ﹤0.01% | 4434 |
|
|
2024
Q4 | $149K | Buy |
59,972
+57,885
| +2,774% | +$144K | ﹤0.01% | 3783 |
|
|
2024
Q3 | $2.4K | Sell |
2,087
-11,384
| -85% | -$13.1K | ﹤0.01% | 4581 |
|
|
2024
Q2 | $14.8K | Buy |
13,471
+1,136
| +9% | +$1.25K | ﹤0.01% | 4331 |
|
|
2024
Q1 | $15.3K | Sell |
12,335
-495,173
| -98% | -$614K | ﹤0.01% | 4351 |
|
|
2023
Q4 | $533K | Buy |
507,508
+495,644
| +4,178% | +$520K | ﹤0.01% | 2647 |
|
|
2023
Q3 | $81.3K | Sell |
11,864
-18,213
| -61% | -$125K | ﹤0.01% | 3308 |
|
|
2023
Q2 | $312K | Sell |
30,077
-46,465
| -61% | -$482K | ﹤0.01% | 3008 |
|
|
2023
Q1 | $619K | Buy |
76,542
+58,256
| +319% | +$471K | ﹤0.01% | 2380 |
|
|
2022
Q4 | $288K | Buy |
18,286
+10,003
| +121% | +$158K | ﹤0.01% | 2863 |
|
|
2022
Q3 | $130K | Sell |
8,283
-5,156
| -38% | -$80.9K | ﹤0.01% | 3274 |
|
|
2022
Q2 | $187K | Buy |
13,439
+5,047
| +60% | +$70.2K | ﹤0.01% | 3225 |
|
|
2022
Q1 | $145K | Sell |
8,392
-9,199
| -52% | -$159K | ﹤0.01% | 3564 |
|
|
2021
Q4 | $256K | Sell |
17,591
-6,752
| -28% | -$98.3K | ﹤0.01% | 3458 |
|
|
2021
Q3 | $438K | Buy |
24,343
+15,330
| +170% | +$276K | ﹤0.01% | 2973 |
|
|
2021
Q2 | $158K | Buy |
9,013
+2,840
| +46% | +$49.8K | ﹤0.01% | 3672 |
|
|
2021
Q1 | $156K | Sell |
6,173
-36,302
| -85% | -$917K | ﹤0.01% | 3489 |
|
|
2020
Q4 | $275K | Buy |
+42,475
| New | +$275K | ﹤0.01% | 3037 |
|
|
2020
Q2 | – | Sell |
-9,838
| Closed | -$10K | – | 5020 |
|
|
2020
Q1 | $10K | Buy |
9,838
+3,652
| +59% | +$3.71K | ﹤0.01% | 4620 |
|
|
2019
Q4 | $12K | Buy |
6,186
+4,073
| +193% | +$7.9K | ﹤0.01% | 4655 |
|
|
2019
Q3 | $2K | Sell |
2,113
-14,741
| -87% | -$14K | ﹤0.01% | 4937 |
|
|
2019
Q2 | $37K | Buy |
16,854
+3,601
| +27% | +$7.91K | ﹤0.01% | 4278 |
|
|
2019
Q1 | $79K | Buy |
13,253
+9,260
| +232% | +$55.2K | ﹤0.01% | 3737 |
|
|
2018
Q4 | $30K | Buy |
3,993
+3,872
| +3,200% | +$29.1K | ﹤0.01% | 4209 |
|
|
2018
Q3 | $1K | Buy |
121
+60
| +98% | +$496 | ﹤0.01% | 4949 |
|
|
2018
Q2 | $1K | Sell |
61
-58
| -49% | -$951 | ﹤0.01% | 4891 |
|
|
2018
Q1 | $2K | Sell |
119
-81
| -41% | -$1.36K | ﹤0.01% | 4740 |
|
|
2017
Q4 | $5K | Buy |
200
+126
| +170% | +$3.15K | ﹤0.01% | 4645 |
|
|
2017
Q3 | $2K | Sell |
74
-4,239
| -98% | -$115K | ﹤0.01% | 4480 |
|
|
2017
Q2 | $117K | Buy |
4,313
+2,726
| +172% | +$73.9K | ﹤0.01% | 3209 |
|
|
2017
Q1 | $47K | Sell |
1,587
-9,884
| -86% | -$293K | ﹤0.01% | 3704 |
|
|
2016
Q4 | $311K | Buy |
11,471
+10,617
| +1,243% | +$288K | ﹤0.01% | 3287 |
|
|
2016
Q3 | $22K | Sell |
854
-127
| -13% | -$3.27K | ﹤0.01% | 4118 |
|
|
2016
Q2 | $18K | Sell |
981
-7,509
| -88% | -$138K | ﹤0.01% | 4234 |
|
|
2016
Q1 | $161K | Buy |
8,490
+6,754
| +389% | +$128K | ﹤0.01% | 3644 |
|
|
2015
Q4 | $47K | Buy |
+1,736
| New | +$47K | ﹤0.01% | 4108 |
|